RETATRUTIDE 15MG - User Manual & Research Protocol Guide

Product Information

• Compound: Retatrutide
• Strength: 15 mg per vial
• Form: Lyophilized powder
• Category: GLP-1 / GIP / Glucagon Receptor Agonist (Research)
• Intended Use: Laboratory research purposes only
• Storage (Unmixed): 2–8°C (Refrigerated)
• Storage (After Reconstitution): Refrigerate and use within 30 days

Retatrutide is being studied as a triple receptor agonist, targeting:

• GLP-1 receptor – Appetite & glucose regulation
• GIP receptor – Metabolic modulation
• Glucagon receptor – Energy expenditure & lipid metabolism

This multi-pathway activity is currently under metabolic and weight-related research evaluation.

Supplies Needed

• Bacteriostatic Water
• U-100 Insulin Syringe
• Alcohol swabs

Step-by-Step Instructions

1. Clean vial tops with alcohol swab.
2. Draw desired amount of bacteriostatic water.
3. Slowly inject water along the inside wall of the vial.
4. Gently swirl until fully dissolved.
   ❗ Do NOT shake.

(Research Reference Structure Only – Not Medical Advice)

Option 1: Add 3 mL Bacteriostatic Water

• Total Peptide: 15 mg
• Final Concentration: 5 mg per mL
  

U-100 Insulin Syringe Conversion:

• 10 units → 0.1 mL → 0.5 mg
• 20 units → 0.2 mL → 1 mg
• 30 units → 0.3 mL → 1.5 mg
• 40 units → 0.4 mL → 2 mg
• 50 units → 0.5 mL → 2.5 mg
  

Option 2: Add 1.5 mL Bacteriostatic Water

• Final Concentration: 10 mg per mL
  

U-100 Insulin Syringe Conversion:

• 5 units → 0.05 mL → 0.5 mg
• 10 units → 0.1 mL → 1 mg
• 15 units → 0.15 mL → 1.5 mg
• 20 units → 0.2 mL → 2 mg

• Frequently studied as once-weekly subcutaneous administration
• Gradual titration models often evaluated in controlled research
• Study duration commonly ranges 8–24 weeks

• For laboratory research use only
• Not for human consumption
• Not FDA approved for therapeutic use
• Maintain sterile technique
• Store refrigerated
• Keep out of reach of children